FLT3 and acute myeloid leukemia: Acute myeloid leukemia (AML) patients with fms-like tyrosine kinase 3 (FLT3) internal tandem duplication (ITD) mutations generally have a worse prognosis, including shorter complete remission (CR) duration and higher rates of recurrence when compared to patients without these mutations.